PUBLICATION
            EPHA2 Segregates with Microphthalmia and Congenital Cataracts in Two Unrelated Families
- Authors
- Harding, P., Toms, M., Schiff, E., Owen, N., Bell, S., Lloyd, I.C., Moosajee, M.
- ID
- ZDB-PUB-210307-20
- Date
- 2021
- Source
- International Journal of Molecular Sciences 22(4): (Journal)
- Registered Authors
- Keywords
- EPHA2, cataracts, congenital, development, eye, genetics, microphthalmia, next-generation sequencing (NGS), whole genome sequencing (WGS), zebrafish
- MeSH Terms
- 
    
        
        
            
                - Alternative Splicing
- Child
- Microphthalmos/etiology
- Microphthalmos/genetics*
- Oligonucleotides, Antisense/genetics
- Cataract/etiology
- Cataract/genetics*
- Male
- Adolescent
- Humans
- Zebrafish/embryology
- Zebrafish/genetics
- High-Throughput Nucleotide Sequencing
- Pedigree
- Animals
- Mutation, Missense
- Middle Aged
- Zebrafish Proteins/genetics
- Adult
- Morpholinos/genetics
- Embryo, Nonmammalian
- Female
- Ephrin-A2/genetics*
 
- PubMed
- 33671840 Full text @ Int. J. Mol. Sci.
            Citation
        
        
            Harding, P., Toms, M., Schiff, E., Owen, N., Bell, S., Lloyd, I.C., Moosajee, M. (2021) EPHA2 Segregates with Microphthalmia and Congenital Cataracts in Two Unrelated Families. International Journal of Molecular Sciences. 22(4).
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                EPHA2 is a transmembrane tyrosine kinase receptor that, when disrupted, causes congenital and age-related cataracts. Cat-Map reports 22 pathogenic EPHA2 variants associated with congenital cataracts, variable microcornea, and lenticonus, but no previous association with microphthalmia (small, underdeveloped eye, ≥2 standard deviations below normal axial length). Microphthalmia arises from ocular maldevelopment with >90 monogenic causes, and can include a complex ocular phenotype. In this paper, we report two pathogenic EPHA2 variants in unrelated families presenting with bilateral microphthalmia and congenital cataracts. Whole genome sequencing through the 100,000 Genomes Project and cataract-related targeted gene panel testing identified autosomal dominant heterozygous mutations segregating with the disease: (i) missense c.1751C>T, p.(Pro584Leu) and (ii) splice site c.2826-9G>A. To functionally validate pathogenicity, morpholino knockdown of epha2a/epha2b in zebrafish resulted in significantly reduced eye size ± cataract formation. Misexpression of N-cadherin and retained fibre cell nuclei were observed in the developing lens of the epha2b knockdown morphant fish by 3 days post-fertilisation, which indicated a putative mechanism for microphthalmia pathogenesis through disruption of cadherin-mediated adherens junctions, preventing lens maturation and the critical signals stimulating eye growth. This study demonstrates a novel association of EPHA2 with microphthalmia, suggesting further analysis of pathogenic variants in unsolved microphthalmia cohorts may increase molecular diagnostic rates.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    